BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10765094)

  • 1. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
    Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
    Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer.
    Sedelaar JP; van Leenders GJ; Hulsbergen-van de Kaa CA; van der Poel HG; van der Laak JA; Debruyne FM; Wijkstra H; de la Rosette JJ
    Eur Urol; 2001 Sep; 40(3):285-93. PubMed ID: 11684844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens.
    Sedelaar JP; van Leenders GJ; Goossen TE; Hulsbergen-van der Kaa CA; van Adrichem NP; Wijkstra H; de la Rosette JJ
    Prostate; 2002 Nov; 53(3):246-53. PubMed ID: 12386926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer.
    Unal D; Sedelaar JP; Aarnink RG; van Leenders GJ; Wijkstra H; Debruyne FM; de la Rosette JJ
    BJU Int; 2000 Jul; 86(1):58-64. PubMed ID: 10886084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
    Madersbacher S; Pedevilla M; Vingers L; Susani M; Marberger M
    Cancer Res; 1995 Aug; 55(15):3346-51. PubMed ID: 7542168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI appearance of prostate following transrectal HIFU ablation of localized cancer.
    Rouvière O; Lyonnet D; Raudrant A; Colin-Pangaud C; Chapelon JY; Bouvier R; Dubernard JM; Gelet A
    Eur Urol; 2001 Sep; 40(3):265-74. PubMed ID: 11684842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
    Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
    Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
    Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
    Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate.
    Van Leenders GJ; Beerlage HP; Ruijter ET; de la Rosette JJ; van de Kaa CA
    J Clin Pathol; 2000 May; 53(5):391-4. PubMed ID: 10889823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation.
    Trabulsi EJ; Calio BP; Kamel SI; Gomella LG; Forsberg F; McCue P; Halpern EJ
    Urology; 2019 Nov; 133():187-191. PubMed ID: 31377256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can color doppler predict the uniformity of HIFU-induced prostate tissue destruction?
    Rouvière O; Curiel L; Chapelon JY; Bouvier R; Ecochard R; Gelet A; Lyonnet D
    Prostate; 2004 Sep; 60(4):289-97. PubMed ID: 15264239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.
    Beerlage HP; van Leenders GJ; Oosterhof GO; Witjes JA; Ruijter ET; van de Kaa CA; Debruyne FM; de la Rosette JJ
    Prostate; 1999 Apr; 39(1):41-6. PubMed ID: 10221265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control of prostate cancer by transrectal HIFU-therapy.
    Kiel HJ; Wieland WF; Rössler W
    Arch Ital Urol Androl; 2000 Dec; 72(4):313-9. PubMed ID: 11221062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of prostate after treatment with high-intensity focused ultrasound.
    Kirkham AP; Emberton M; Hoh IM; Illing RO; Freeman AA; Allen C
    Radiology; 2008 Mar; 246(3):833-44. PubMed ID: 18223121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Pfeiffer D; Berger J; Gross AJ
    BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
    Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
    Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
    Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
    Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.